Systemic Metastasis-Targeted Nanotherapeutic Reinforces Tumor Surgical Resection and Chemotherapy

Investigators designed a systemic metastasis-targeted nanotherapeutic (H@CaPP) to hinder the multiple steps of tumor metastasis. H@CaPP efficiently inhibited tumor metastasis and prolonged overall survival of 4T1 mammary tumor-bearing mice.